{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T10:02:27Z","timestamp":1793613747432,"version":"4.5.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2007,3,7]],"date-time":"2007-03-07T00:00:00Z","timestamp":1173225600000},"content-version":"vor","delay-in-days":1557,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,12]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Incidence of liver disease (LD) associated with cystic fibrosis (CF) and its clinical characterization still is unsettled. We have assessed prospectively the incidence and risk factors of this complication, and its impact on the clinical course of CF. Between 1980 and 1990, we enrolled 177 CF patients without LD in a systematic clinical, laboratory, ultrasonography screening program of at least a 10-year duration. During a 14-year median follow-up (2,432 patient-years), 48 patients developed LD, with cirrhosis already present in 5. Incidence rate (number of cases per 100 patient-years) was 1.8% (95% confidence interval: 1.3-2.4), with sharp decline after the age of 10 years and higher risk in patients with a history of meconium ileus (incidence rate ratio, 5.5; 2.7-11), male sex (2.5; 1.3-4.9), or severe mutations (2.4; 1.2-4.8) at multivariate analysis. Incidence of cirrhosis was 4.5% (2.3-7.8) during a median period of 5 years from diagnosis of liver disease. Among the 17 cirrhotic patients, 13 developed portal hypertension, 4 developed esophageal varices, 1 developed liver decompensation requiring liver transplantation. Development of LD did not condition different mortality (death rate ratio, 0.4; 0.1-1.5) or higher incidence of other clinically relevant outcomes. In conclusion, LD is a relatively frequent and early complication of CF, whose detection should be focused at the first life decade in patients with history of meconium ileus, male sex, or severe genotype. Although LD does not condition a different clinical course of CF, in some patients it may progress rapidly and require liver transplantation. (Hepatology2002;36:1374-1382).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.1840360613","type":"journal-article","created":{"date-parts":[[2007,3,10]],"date-time":"2007-03-10T20:34:13Z","timestamp":1173558853000},"page":"1374-1382","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":343,"title":["Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome"],"prefix":"10.1097","volume":"36","author":[{"given":"Carla","family":"Colombo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Maria","family":"Battezzati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Crosignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Morabito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Costantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Padoan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Giunta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1002\/hep.1840360613-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3476(05)83478-X","article-title":"The changing epidemiology of cystic fibrosis","volume":"122","author":"Fitzsimmons","year":"1993","journal-title":"J Pediatr"},{"key":"10.1002\/hep.1840360613-BIB2|cit2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00005176-200104000-00005","article-title":"Markers of cystic fibrosis-associated liver disease","volume":"32","author":"Narkewicz","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1002\/hep.1840360613-BIB3|cit3","unstructured":"2001"},{"issue":"Suppl 1","key":"10.1002\/hep.1840360613-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005176-199900001-00001","article-title":"Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group","volume":"28","author":"Sokol","year":"1999","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1002\/hep.1840360613-BIB5|cit5","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1055\/s-2001-19030","article-title":"Cholangiocyte biology and cystic fibrosis liver disease","volume":"21","author":"Feranchak","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1002\/hep.1840360613-BIB6|cit6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1053\/jhep.2000.9111","article-title":"Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis","volume":"32","author":"Kinnman","year":"2000","journal-title":"Hepatology"},{"key":"10.1002\/hep.1840360613-BIB7|cit7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJM198802113180602","article-title":"Liver disease and common bile-duct stenosis in cystic fibrosis","volume":"318","author":"Gaskin","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1002\/hep.1840360613-BIB8|cit8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1055\/s-2007-1007316","article-title":"Hepatobiliary disease in cystic fibrosis","volume":"14","author":"Colombo","year":"1994","journal-title":"Semin Liver Dis"},{"key":"10.1002\/hep.1840360613-BIB9|cit9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/adc.68.5.653","article-title":"Liver cirrhosis in cystic fibrosis. Therapeutic implications and long-term follow-up","volume":"68","author":"Feigelson","year":"1993","journal-title":"Arch Dis Child"},{"key":"10.1002\/hep.1840360613-BIB10|cit10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0168-8278(99)80166-4","article-title":"Outcome of liver cirrhosis in cystic fibrosis. Management of portal hypertension","volume":"31","author":"Debray","year":"1999","journal-title":"J Hepatol"},{"key":"10.1002\/hep.1840360613-BIB11|cit11","first-page":"318","article-title":"Natural history of liver disease and cirrhosis in cystic fibrosis [Abstract]","volume":"29","author":"Laenerts","year":"2000","journal-title":"Pediatr Pulmonol"},{"key":"10.1002\/hep.1840360613-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.510300527","article-title":"Natural history of liver disease in cystic fibrosis","volume":"30","author":"Lindblad","year":"1999","journal-title":"Hepatology"},{"key":"10.1002\/hep.1840360613-BIB13|cit13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/adc.81.2.129","article-title":"The evolution of liver disease in cystic fibrosis","volume":"81","author":"Ling","year":"1999","journal-title":"Arch Dis Child"},{"key":"10.1002\/hep.1840360613-BIB14|cit14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/thx.52.4.313","article-title":"A prognostic model for prediction of survival in cystic fibrosis","volume":"52","author":"Hayllar","year":"1997","journal-title":"Thorax"},{"key":"10.1002\/hep.1840360613-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJM199204303261804","article-title":"Prediction of mortality in patients with cystic fibrosis","volume":"326","author":"Kerem","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1002\/hep.1840360613-BIB16|cit16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/aje\/153.4.345","article-title":"Predictive 5-year survivorship model of cystic fibrosis","volume":"153","author":"Liou","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1002\/hep.1840360613-BIB17|cit17","first-page":"725","article-title":"Changes in the normal maximal expiratory flow-volume curve with growth and aging","volume":"127","author":"Knudson","year":"1983","journal-title":"Am Rev Respir Dis"},{"key":"10.1002\/hep.1840360613-BIB18|cit18","first-page":"260","article-title":"Recruiting collapsed lung through collateral channels with positive end-expiratory pressure","volume":"60","author":"Andersen","year":"1979","journal-title":"Scand J Respir Dis"},{"key":"10.1002\/hep.1840360613-BIB19|cit19","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/hep.1840160412","article-title":"Ursodeoxycholic acid therapy in cystic fibrosis associated liver disease: a dose-response study","volume":"16","author":"Colombo","year":"1992","journal-title":"Hepatology"},{"key":"10.1002\/hep.1840360613-BIB20|cit20","first-page":"1178","article-title":"Genetic determination of exocrine pancreatic function in cystic fibrosis","volume":"50","author":"Kristidis","year":"1992","journal-title":"Am J Hum Genet"},{"key":"10.1002\/hep.1840360613-BIB21|cit21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/adc.51.3.170","article-title":"Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty","volume":"51","author":"Tanner","year":"1976","journal-title":"Arch Dis Child"},{"key":"10.1002\/hep.1840360613-BIB22|cit22","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0168-8278(99)80299-2","article-title":"Liver involvement in cystic fibrosis","volume":"31","author":"Colombo","year":"1999","journal-title":"J Hepatol"},{"key":"10.1002\/hep.1840360613-BIB23|cit23","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/adc.66.6.698","article-title":"Prevalence of liver disease in cystic fibrosis","volume":"66","author":"Scott-Jupp","year":"1991","journal-title":"Arch Dis Child"},{"key":"10.1002\/hep.1840360613-BIB24|cit24","first-page":"402A","article-title":"Prospective evaluation of liver blood tests during the first 8 years of life in children with cystic fibrosis identified by newborn screening [Abstract]","volume":"4","author":"Sokol","year":"1994","journal-title":"Hepatology"},{"key":"10.1002\/hep.1840360613-BIB25|cit25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0168-8278(95)80444-7","article-title":"An ultrasound scoring system for the diagnosis of liver disease in cystic fibrosis","volume":"22","author":"Williams","year":"1995","journal-title":"J Hepatol"},{"key":"10.1002\/hep.1840360613-BIB26|cit26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1148\/radiology.211.1.r99ap13229","article-title":"Liver disease in children with cystic fibrosis: US-biochemical comparison in 195 patients","volume":"211","author":"Patriquin","year":"1999","journal-title":"Radiology"},{"key":"10.1002\/hep.1840360613-BIB27|cit27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0009-9260(05)80350-2","article-title":"Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease","volume":"43","author":"Joseph","year":"1991","journal-title":"Clin Radiol"},{"key":"10.1002\/hep.1840360613-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2214\/ajr.134.5.1005","article-title":"Cystic fibrosis: its characteristic appearance on abdominal sonography","volume":"143","author":"Willi","year":"1980","journal-title":"AJR Am J Roentgenol"},{"key":"10.1002\/hep.1840360613-BIB29|cit29","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0022-3476(94)70361-2","article-title":"Analysis of risk factors for the development of liver disease associated with cystic fibrosis","volume":"124","author":"Colombo","year":"1994","journal-title":"J Pediatr"},{"key":"10.1002\/hep.1840360613-BIB30|cit30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1542\/peds.103.1.52","article-title":"Clinical and genetic risk factors for CF-related liver disease","volume":"103","author":"Wilschanski","year":"1999","journal-title":"Pediatrics"},{"key":"10.1002\/hep.1840360613-BIB31|cit31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/adc.81.2.125","article-title":"Retrospective review of cystic fibrosis presenting as infantile liver disease","volume":"81","author":"Shapira","year":"1999","journal-title":"Arch Dis Child"},{"key":"10.1002\/hep.1840360613-BIB32|cit32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-3476(95)70528-7","article-title":"Incidence of liver disease in patients with cystic fibrosis and meconium ileus","volume":"125","author":"Lindblad","year":"1995","journal-title":"J Pediatr"},{"key":"10.1002\/hep.1840360613-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.101.4.e7","article-title":"Long-term outcome after neonatal meconium obstruction","volume":"101","author":"Fuchs","year":"1998","journal-title":"Pediatrics"},{"issue":"Suppl","key":"10.1002\/hep.1840360613-BIB34|cit34","first-page":"340","article-title":"Regular screening for serum liver enzymes and appropriate early therapy with ursodeoxycholic acid delays severe liver disease in CF [Abstract]","volume":"22","author":"Kappler","year":"2001","journal-title":"Pediatr Pulmonol"},{"key":"10.1002\/hep.1840360613-BIB35|cit35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000029497","article-title":"Genotype and phenotype in cystic fibrosis","volume":"67","author":"Zielenski","year":"2000","journal-title":"Respiration"},{"issue":"Suppl","key":"10.1002\/hep.1840360613-BIB36|cit36","first-page":"340","article-title":"Complex multigenic inheritance influences the development of severe CF liver disease [Abstract]","volume":"22","author":"Friedman","year":"2001","journal-title":"Pediatr Pulmonol"},{"key":"10.1002\/hep.1840360613-BIB37|cit37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/9635","article-title":"Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13 [Letter]","volume":"22","author":"Zielenski","year":"1999","journal-title":"Nat Genet"},{"key":"10.1002\/hep.1840360613-BIB38|cit38","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/hep.1840090417","article-title":"The effect of estrogen and tamoxifen on hepatocyte proliferation in vivo and in vitro","volume":"9","author":"Francavilla","year":"1989","journal-title":"Hepatology"},{"key":"10.1002\/hep.1840360613-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1053\/gast.2000.20184","article-title":"Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats","volume":"119","author":"Alvaro","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1002\/hep.1840360613-BIB40|cit40","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.1840150418","article-title":"Genotype analysis for DF 508, G551D and R553X mutations in children and young adults with cystic fibrosis with and without liver disease","volume":"15","author":"Duthie","year":"1992","journal-title":"Hepatology"},{"issue":"Suppl","key":"10.1002\/hep.1840360613-BIB41|cit41","first-page":"244","article-title":"The association between liver disease and mutations of the cystic fibrosis gene [Abstract]","volume":"8","author":"Kovesi","year":"1992","journal-title":"Pediatr Pulmonol"},{"key":"10.1002\/hep.1840360613-BIB42|cit42","first-page":"371","volume-title":"Diseases of the liver and biliary system","author":"Sherlock","year":"1997"},{"key":"10.1002\/hep.1840360613-BIB43|cit43","volume-title":"The Cochrane Library","author":"Cheng","year":"2000"},{"key":"10.1002\/hep.1840360613-BIB44|cit44","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/hep.510230627","article-title":"Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial","volume":"23","author":"Colombo","year":"1996","journal-title":"Hepatology"},{"key":"10.1002\/hep.1840360613-BIB45|cit45","first-page":"129","volume-title":"Screening in chronic disease","author":"Morrison","year":"1992"},{"key":"10.1002\/hep.1840360613-BIB46|cit46","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/archinte.1969.00300130105014","article-title":"The epidemiology of cancer therapy. II. The clinical course: data, decisions, and temporal demarcations","volume":"123","author":"Feinstein","year":"1969","journal-title":"Arch Intern Med"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.1840360613","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.1840360613","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200212000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T11:29:36Z","timestamp":1733052576000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200212000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":46,"aliases":["10.1053\/jhep.2002.37136"],"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.1840360613","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2002,12]]}}}